Nano-X Imaging reported second-quarter revenue of $4.2 million, up 37% year over year, while booking a $40.7 million impairment charge and warning that its remaining cash raises substantial doubt about its ability to continue as a going concern. The company held $31.4 million as of June 30, down from $60 million as of December 31, 2025, and CFO Guy Nathanzon said the resources raise substantial doubt about the going-concern outlook. The impairment charge, triggered by a falling share price and lower revenue forecasts for the AI unit, dragged GAAP gross margin to negative 1,051% from negative 107% a year earlier and pushed the GAAP net loss to $55.5 million. Teleradiology grew 14% year over year to $3 million, the AI and software line added $1 million, and the first Nanox Imaging Network site, in Philadelphia, has begun collecting insurance payments of $200 to $700 per claim, with management projecting a fully utilized site could generate $500,000 to $1 million a year. CEO Erez Meltzer said commercialization has taken longer than expected, and the company's response is a restructuring that idles chip fabrication in South Korea, cuts that workforce by 67%, trims Israeli headcount by 15%, and shifts manufacturing to third-party partners, a plan expected to save just $2 million a year starting in 2027.
Nano X Imaging LtdQ2 revenue grew 37% but a $40.7M impairment, negative 1,051% gross margin, $55.5M net loss and going-concern doubt over dwindling cash dominate the report.
